Oncology and Radiology Device Market, By Technology (Linear Accelerators, Cobalt-60, High-Dose Radiation, and Low-Dose Radiation), By Therapy (External Radiation Therapy and Internal Radiation Therapy or Brachytherapy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Market for oncology and radiology devices was estimated to be worth US$ 88.7 billion in 2024 and is expected to increase at a compound annual growth rate (CAGR) of 9.30% to reach US$ 199.3 billion by 2034.

Numerous approaches for cancer diagnosis and therapy are included in oncology and radiology services. Examples of oncology devices that assist patients and medical professionals in identifying, diagnosing, treating, and monitoring premalignant and malignant disorders are combination device solutions and nucleic acid-based vitro diagnostics. As a cancer treatment, radiation therapy uses high-energy X-rays or other particles to destroy cancer cells.

Proton treatment systems, brachytherapy equipment, and linear accelerators are some of the devices that are used to precisely target malignant tumors with radiation therapy while protecting healthy tissue. Over the course of the projection period, the market will be driven by factors such as an aging population, increasing cancer incidence and prevalence, technical breakthroughs in cancer detection and treatment equipment, and encouraging initiatives aimed at reducing costs without sacrificing patient quality of care.

In addition, the detection and treatment of cancer have been transformed by the quick advances in technology. The market is growing as a result of enhanced patient outcomes and more treatment options, including targeted medications, immunotherapies, and molecular testing, thanks to innovative medical devices. Over the course of the projection period, the target market's growth may be hampered by these gadgets' high cost.